Analysis of EEG dynamics in epileptic children during carbamazepine therapy
By:
References
- 1. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47:1094-120.
- 2. Goodridge PMG, Shorvon SD. Epileptic seizures in a population of 6000. 2 Treatment and prognosis. Brit Med. 1983; l:645-7.
- 3. Hart YM, Sander J WAS, Johnson AL, Shorvon SD. National general practice study of epilepsy: recurrence after a first seizure. Lancet. 1990; 1:1271-4.
- 4. Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39(1):5-17.10.1111/j.1528-1157.1998.tb01268.x
- 5. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487-9.10.1212/WNL.33.11.1487
- 6. Genton P, Gelisse R, Thomas P., Dravet C. Do Caramazepine and Pheniton aggravate juvenile myclonic epilepsy? Neurology. 2000; 55:1106-9.10.1212/WNL.55.8.1106
- 7. Stefan H, Wang Y, Pauli E, Schmidt B. A new approach in anti-epileptic drug evaluation. Eur J Neurol. 2004; 11: 467-73.10.1111/j.1468-1331.2004.00812.x
- 8. Corda D, Gelisse P, Dravet C, Baldy-Mouiner M. Incidence of drug-induced aggravation in Benign epilepsy with centotemporal spikes. Epilepsia. 2001; 42: 754-59.
- 9. Horn C, Ater S, Hurst D. Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol. 1986; 2:340-5.10.1016/0887-8994(86)90074-3
- 10. Beaumanoir A. The Landay-Kleffner syndroe. In: Roger J, Bureau M, Dravet C, Genton CP, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 231-43.
- 11. Tassinari C, Bureau M, Dravet C. Epilepsy with continuous spikes and waves during slow sleep: otherwise with described with electrical status epilepticus during slow sleep (ESES) In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, editors. Epilepsy syndromes in infancy, childhood and adolescence. 2nd ed. Paris:John Libbey, 1992. p. 254-56.
- 12. Rho J M, Shankar R. The pharmacological basis of antiepileptic drugs action. Epilepsia. 1999; 40:1471-83.
- 13. Macdonald RL, Meldrum BS. Principles of antiepileptic drug action. In: Levy R, Mattson R, Meldrum B. Penry JK, Dreifuss FE, editors. Antiepileptic drugs. NewYork;Raven Press, 1989. p. 59-83.
- 14. Granger P, Biton B, Faure C., Vige X, Depoortere H, Graham D, Langer SZ, Scatton B, Avenet P. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Mol Pharmacol. 1995; 47:1189-96.
- 15. Sramek J, Zarotsky V, Cutler N. Generalised anxiety disorder: treatment options. Drugs. 2002; 62:1635-48.
- 16. Clemens B, Piros P, Bessenyei M, Hollody K. Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy. Clin Neurophysiol. 2007; 118: 910-7.10.1016/j.clinph.2006.11.016
- 17. Clemens B, Menes A, Piros P, Bessenyei M, Altmann A, Jerney J, et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res. 2006; 70:190-9.10.1016/j.eplepsyres.2006.05.003
- 18. Salinsky MC, Oken BS, Storzbach D, Dodrill CB. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia. 2003; 44: 1042-50.
- 19. Neufeld MY, Kogan E, Chistik V, Korczyn AD. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. Clin Neuropharmacol. 1999; 22:80-6.
- 20. Drake ME, Padamadan H, Newell SA. Interictal quantitative EEG in epilepsy. Seizure. 1998; 7:39-42.
- 21. Salinsky MC, Oken BS, Morehead L. Intraindividual analysis of antiepileptic drug effects on EEG background rhythms. Electroencephalogr Clin Neurophysiol. 1994 ; 90:186-93.10.1016/0013-4694(94)90090-6
- 22. Herkes GK, Lagerlund TD, Sharbrough FW, Eadie MJ. Effects of antiepileptic drug treatment on the background frequency of EEGs in epileptic patients. J Clin Neurophysiol. 1993; 10:210-6.
- 23. Besser R, Hornung K, Theisohn M, Rothacher G, Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol. 1992; 83:19-23.10.1016/0013-4694(92)90128-5
- 24. Kalviainen R, Aikia M, Partanen J, Sivenius J, Mumford J, Saksa M, et al. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J Child Neurol. 1991; Suppl 2: 60-9.
- 25. Miyauchi T, Endo K, Yamaguchi T, Hagimoto H. Computerized analysis of EEG background activity in epileptic patients. Epilepsia. 1991; 32:870-81.10.1111/j.1528-1157.1991.tb05544.x
- 26. Fonseca LC, Tedrus GM, Chiodi MG, Cerqueira JN, Duran MH. Quantitative electroencephalography in children with benign childhood epilepsy with centrotemporal spikes: analysis of band power. Arq Neuropsiquiatr. 2004; 62:455-8.
- 27. Camfield P, Gordon K, Camfield C, Tibbles J, Dooley J, Smith B. EEG results are rarely the same if repeated within six months in childhood epilepsy. Can J Neurol Sci. 1995; 22:297-300.10.1017/S0317167100039512
- 28. Konishi T, Naganuma Y, Hongou K, Murakami M, Yamatani M, Okada T. Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy. Clin Electroencephalogr. 1995; 26:113-9.
- 29. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of the epilipsies and epileptic syndromes. Epilepsia, 1989; 30:389-99.
- 30. American EEG Society Guidelines in EEG, 1-7, 13 (Revised 1994). J Clin Neurophysiol. 1994; 11: 1-143.
- 31. Harmony T, Hinojosa G, Marosi E, Becker J, Rodriguez M, Reyes A, et al. Correlation between EEG spectral parameters and educational evaluation. Inter J Neurosci. 1990; 54:147-55.
- 32. Benninger C, Matthis P, Scheffner D. EEG development of healthy boys and girls. Results of a longitudinal study. Electroencephalogr Clin Neurophysiol. 1984; 57:1-12.
- 33. Niedermeyer E. Maturation of the EEG: development of waking and sleep patterns. In: Electroencephalography. Basic Principles, Clinical Applications and Related Fields. Niedermeyer E, Lopes Da Silva F, editors. Urban & Schvarzenberg, 1983, p. 107-30.
- 34. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin. 1945; 1: 80-3.
- 35. Genton P, McMenamin J. Aggravation of seizure by antiepileptic drugs: what to do in clinical practice. Epilepsia. 1998; 39:26-9.10.1111/j.1528-1157.1998.tb05119.x
- 36. Frost JD Jr, Hrachovy RA, Glaze DG, Rettig GM. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. Clin Neurophysiol. 1995; 1:57-63.
- 37. Wu X, Xiao CH. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clin Electroencephalogr. 1996; 27:40-5.
- 38. Khachidze I, Maloletnev V, Mamukashvili M. Effect of the sodium valproate on EEG pattern in epileptic patients. Proc Georgian Acad Sci. 2006; 5:1109-14.
- 39. Salinsky MC, Binder LM, Oken BS, Storzbach D, Aron CR, Dodrill CB. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia. 2002; 5:482-90.
- 40. Garcia-Borreguero D, Bronisch T, Apelt S, Yassouridis A, Emrich H M. Treatment of benzodiazepine withdrawal symptoms with carbamazepine. Eur Arch Psychiatry Clin Neurosci. 1991; 3:145-50.10.1007/BF02219713
- 41. Stefan H, Fraunberger B. Valproate sustained release in the treatment of epilepsy. Fortschr Neurol Psychiatr. 2005; 73:681-6.
- 42. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006; 2:790-8.
- 43. Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005; 63:141-9.10.1016/j.eplepsyres.2005.02.002
- 44. Goyal V, Bhatia M, Behari M. Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability. J Transcranial Magnetic Evaluation. 2004; 2: 224-7.
- 45. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurology. 2002; 9:41-7.
- 46. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia. 1994; 35:1154-9.10.1111/j.1528-1157.1994.tb01782.x
- 47. Guerrini R, Belmonte A, Genton P. Antiepileptic druginduced worsening of seizures in children. Epilepsia. 1998; 39(Suppl 3):2-10.
- 48. Stefan H, Lopes da Silva FH, Löscher W, Schmidt D, Perucca E, Brodie MJ. et al. Epileptogenesis and rational therapeutic strategies. Acta Neurol Scand. 2006; 113:139-55.
Language: English
Page range: 37 - 47
Published on: Apr 13, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 times per year
Keywords:
Related subjects:
© 2018 Irma Khachidze, Manana Gugushvili, Nana Kapanadze, Aleksandre Koreli, Marina Mamukashvili, Victor Maloletnev, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.